October 12, 2021 | Diversity, Equality, clinical trials, lupus, lupusawareness, patient recruitment
In this second October’s blog, we will be looking into Lupus in clinical trials: its symptoms, complications, treatments, incidence and focus on diversity.
October marks Lupus Awareness month in which education and awareness of lupus is brought to light through several initiatives. Lupus is an autoimmune disease as it causes the immune system to attack healthy cells in the body.
It has been long established that 90% of individuals with lupus are women, with the illness being up to three times more prevalent in women of colour than Caucasian women. Moreover, Lupus has been previously ranked amongst the top 20 causes of death in all women, however this figure rose to distressing new levels as lupus is now recognized as the 5th and 6th leading cause of death among Black and Hispanic women aged 15-34.
Read the full blog here
This content was provided by Innovative Trials
Company Details
Latest Content from Innovative Trials
In this second October’s blog, we will be looking into Lupus in clinical trials: its symptoms, complications, treatments, incidence and focus on diversity.
This Black History Month, we discuss the black representation in clinical trials and the effects COVID-19 has had on the black community.
Innovative Trials, has been named Best Global Patient Recruitment Company by the Healthcare & Pharmaceutical Awards 2021.
Innovative Trials was awarded the Queen’s Award for Enterprise, and this video includes highlights of the ceremony days at the HQ in Letchworth.
Innovative Trials presented with Queen’s Award for international excellence in clinical trial patient recruitment
